CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $960 | +90.5% | 64,404 | +39.9% | 0.00% | 0.0% |
| Q2 2023 | $504 | -74.8% | 46,023 | +7780.7% | 0.00% | – |
| Q2 2022 | $2,000 | -97.8% | 584 | -98.0% | 0.00% | – |
| Q1 2022 | $92,000 | -8.0% | 29,580 | 0.0% | 0.00% | – |
| Q4 2021 | $100,000 | -7.4% | 29,580 | -0.4% | 0.00% | – |
| Q3 2021 | $108,000 | -55.0% | 29,701 | -46.0% | 0.00% | – |
| Q2 2021 | $240,000 | -2.8% | 54,965 | +1.0% | 0.00% | – |
| Q1 2021 | $247,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
| Q4 2020 | $312,000 | -20.8% | 54,400 | 0.0% | 0.00% | – |
| Q3 2020 | $394,000 | +107.4% | 54,400 | 0.0% | 0.00% | – |
| Q2 2020 | $190,000 | +134.6% | 54,400 | 0.0% | 0.00% | – |
| Q1 2020 | $81,000 | -24.3% | 54,400 | 0.0% | 0.00% | – |
| Q4 2019 | $107,000 | -61.6% | 54,400 | 0.0% | 0.00% | – |
| Q3 2019 | $279,000 | -44.8% | 54,400 | -22.8% | 0.00% | -100.0% |
| Q2 2019 | $505,000 | -30.0% | 70,500 | +29.8% | 0.00% | 0.0% |
| Q1 2019 | $721,000 | +68.9% | 54,300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $427,000 | -41.2% | 54,300 | -17.1% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | -17.4% | 65,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $879,000 | – | 65,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |